Skip to content

Insider · CIK 0001609405

Khuong Chau Quang

Reports to the SEC for 10 companies · SAN DIEGO, CA

Transactions

50

Companies

10

Filings

13

CIK

0001609405

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2023-06-22NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award—
2023-06-14Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award—
2023-06-14DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2022-11-11Fusion Pharmaceuticals Inc.A Award+$100K
2022-06-23NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award—
2022-06-14Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award—
2022-06-14DMRADamora Therapeutics, Inc. · /s/ Jonathan Freve, attorney-in-factA Award—
2021-11-17DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2021-06-24NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award—
2021-06-04Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award—
2021-05-26DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award—
2021-04-20SYBXSYNLOGIC, INC.A Award+$5M
2020-11-02DMRADamora Therapeutics, Inc.C Conversion—
2020-11-02DMRADamora Therapeutics, Inc.C Conversion—
2020-11-02DMRADamora Therapeutics, Inc.C Conversion—
2020-11-02DMRADamora Therapeutics, Inc.P Purchase+$7.86M
2020-11-02DMRADamora Therapeutics, Inc.P Purchase+$3.14M
2020-11-02DMRADamora Therapeutics, Inc. · Series C-2 Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series C-2 Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series C-4 Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series C-4 Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series C-5 Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series C-5 Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series D Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series D Preferred StockC Conversion—
2020-11-02DMRADamora Therapeutics, Inc. · Series D Preferred StockC Conversion—
2020-10-09INSPInspire Medical Systems, Inc.A Award+$11.8K
2020-09-25DMRADamora Therapeutics, Inc. · Series D Preferred StockA Award−$4.02M
2020-09-25DMRADamora Therapeutics, Inc. · Series D Preferred StockA Award−$1.61M
2020-09-25DMRADamora Therapeutics, Inc. · Series D Preferred StockA Award−$2M
2020-08-18INSPInspire Medical Systems, Inc.S Sale−$4.73M
2020-08-17INSPInspire Medical Systems, Inc.S Sale−$10.2M
2020-08-14INSPInspire Medical Systems, Inc.S Sale−$2.21M
2020-08-13INSPInspire Medical Systems, Inc.S Sale−$3.22M
2020-08-12INSPInspire Medical Systems, Inc.S Sale−$4.59M
2020-08-11INSPInspire Medical Systems, Inc.S Sale−$4.22M
2020-08-10INSPInspire Medical Systems, Inc.S Sale−$5.02M
2020-08-07INSPInspire Medical Systems, Inc.S Sale−$3.08M
2020-07-10INSPInspire Medical Systems, Inc.A Award—
2020-06-30Fusion Pharmaceuticals Inc.C Conversion—
2020-06-30Fusion Pharmaceuticals Inc.P Purchase+$12M
2020-06-30Fusion Pharmaceuticals Inc.P Purchase+$3.27M
2020-06-30Fusion Pharmaceuticals Inc.Class B Preferred SharesC Conversion—
2020-06-25Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award—
2020-06-11NXTCNextCure, Inc. · Stock Option (Right to Buy)A Award—
2020-06-04SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award—
2020-06-02Fusion Pharmaceuticals Inc.Class B Preferred SharesP Purchase+$6.84M
2020-04-30INSPInspire Medical Systems, Inc. · Stock Option (right to buy)A Award—
2020-04-10INSPInspire Medical Systems, Inc.A Award—
2020-03-06INSPInspire Medical Systems, Inc.S Sale−$41.8M